Oncotarget is a publicly available medical journal established with the goal to make medical research results accessible and to spread awareness of cancer and how it is treated. First published in 2010 and with weekly new releases the medical journal covers recently conducted research, primarily in the field of oncology. Oncotarget’s two chief editors, Mikhail Blagosklonny M.D and DrAndrei V. Gudkov each have extensive knowledge in the area of medicine. Visit ResearchGate to keep up to date with Mikhail’s latest work.
Professor Mikhail Blagosklonny is a scientist originating from Russia. Currently working in New York City at the renowned Roswell Park Cancer Institute, Prof. Mikhail Blagosklonny conducts research on targeted cancer therapies and a number of ways of protecting cells from damage caused by cancer, as well as studying the ageing process and various life-extension drugs. In his earlier years, Professor Mikhail Blagosklonny studied at the First Pavlov State Medical University of St. Petersburg where he first earned an M. D. in internal medicine and later a Ph. D. in cardiology and experimental medicine. Mikhail Blagosklonny M. D. also holds the position of associate editor for the medical journals called Ageing and Cell Cycle. Just like Oncotarget, the two other medical journals coincide well with Prof. Mikhail Blagosklonny’s fields of research.
Doctor Andrei V. Gudkov is a valuable member of the Roswell Park Cancer Institute as well. Dr Andrei Gudkov holds the position of Chair of the Department of Cell Stress Biology. Not only that, but he is also the position of Senior Vice President of Basic Science. Dr Gudkov has considerably contributed to the Cancer Institute. He received his education from the Cancer Research Center, in what at the time was USSR. He earned his Doctorate of Science degree in Molecular Biology (D. Sci). Dr. Andrei Gudkov has contributed to the world of medicine through his written works as well. He has been the author of a wide number of articles regarding his research, and he has also written many articles in collaboration with other doctors. He has published over a hundred articles on various medical topics. His research primarily consists of drug and gene discovery and cancer treatment. View Mikhail’s profile on Google Scholar